GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 73 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $172 | -11.8% | 100 | 0.0% | 0.00% | – |
| Q2 2023 | $195 | -29.9% | 100 | 0.0% | 0.00% | – |
| Q1 2023 | $278 | -19.4% | 100 | 0.0% | 0.00% | – |
| Q4 2022 | $345 | – | 100 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 100 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | – | 100 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 100 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | -50.0% | 100 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,102,929 | $18,059,047,000 | 4.95% |
| Svennilson Peter | 3,102,934 | $18,059,000 | 2.29% |
| Casdin Capital, LLC | 2,270,000 | $13,211,000 | 1.40% |
| FRAZIER MANAGEMENT LLC | 2,061,758 | $11,999,000 | 1.36% |
| Redmile Group, LLC | 3,068,194 | $17,857,000 | 0.50% |
| Alphabet Inc. | 929,022 | $5,407,000 | 0.36% |
| Bleichroeder LP | 169,039 | $984,000 | 0.26% |
| Leap Investments LP | 14,400 | $84,000 | 0.12% |
| DAFNA Capital Management LLC | 50,000 | $291,000 | 0.12% |
| Blackstone Inc. | 2,567,445 | $14,943,000 | 0.11% |